Sun Pharma acquires urinary health product portfolio from Romania's Fiterman Pharma

Publicly listed Sun Pharmaceutical Industries Ltd has acquired the "Uractiv" brand portfolio from Romania-based Fiterman Pharma. The portfolio - which comprises food supplements including minerals, vitamins, adjuvants and medical devices used for maintaining urinary tract health - across 12 SKUs has annualised revenues of approximately USD 8.7 million.